Scottsdale-based CND Life Sciences raises $4.5M in seed funding


Scottsdale-based CND Life Sciences recently closed on a $4.5 million seed funding round to further accelerate commercialization of its test to detect neurodegenerative diseases.

Previous U.S. Bank hires Joe Neuberger's successor at Global Fund Services in Milwaukee
Next 40 Under 40: Ashley Mangum, Kids' Mental Health Pierce County